Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMC 547740)

Published in Appl Microbiol on November 01, 1968

Authors

P Braun, J R Tillotson, C Wilcox, M Finland

Articles cited by this

IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE. Appl Microbiol (1965) 6.95

Cephalexin, a new orally absorbed cephalosporin antibiotic. Appl Microbiol (1967) 2.75

CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS. Am J Med Sci (1964) 2.63

Cephaloridine activity in vitro and absorption and urinary excretion in normal young men. Am J Med Sci (1966) 2.09

Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) (1966) 1.99

Clinical evaluation of cephaloridine. Arch Intern Med (1968) 1.59

Levels of penicillin in serum of newborn infants. Am J Dis Child (1966) 1.18

In vitro antimicrobial activity and human pharmacology of cephaloglycin. Appl Microbiol (1968) 1.18

Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Yale J Biol Med (1968) 1.08

Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.93

Clinical experience with cephaloglycin. Antimicrob Agents Chemother (Bethesda) (1967) 0.92

Comparative studies of ampicillin, cephalothin and a new cephalosporin derivative, cephaloglycin. Am J Med Sci (1968) 0.90

Antimicrobial activity and pharmacological behavior of cephaloglycine. Antimicrob Agents Chemother (Bethesda) (1967) 0.83

Resistance and cross-resistance of Staphylococcus aureus, Escherichia coli, and Aerobacter species to cephalosporins and semisynthetic penicillins. Antimicrob Agents Chemother (Bethesda) (1966) 0.83

Articles by these authors

ANTIBODY RESPONSE TO INFECTIONS WITH THE NEWLY CLASSIFIED TYPES OF PNEUMOCOCCI (COOPER). J Clin Invest (1934) 10.11

Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci (1969) 10.08

STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI. J Clin Invest (1940) 9.39

COLD AGGLUTININS (AUTOHEMAGGLUTININS) IN PRIMARY ATYPICAL PNEUMONIAS. Science (1943) 9.20

Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma. J Lab Clin Med (1971) 8.13

OBSERVATIONS ON THE INHIBITION OF SULFONAMIDE ACTION BY PARA-AMINOBENZOIC ACID. J Clin Invest (1941) 8.03

Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis (1970) 7.72

Observations on Bacteria Sensitive to, Resistant to, and Dependent upon Streptomycin. J Bacteriol (1948) 7.56

Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother (1975) 6.82

Bacteriologic Studies on Aureomycin. J Bacteriol (1948) 5.91

A COMPARATIVE STUDY OF THE BLOOD CONCENTRATIONS AND URINARY EXCRETION OF SULFAPYRIDINE AND SULFANILAMIDE AFTER SINGLE DOSES OF SULFAPYRIDINE AND RELATED COMPOUNDS ADMINISTERED BY VARIOUS ROUTES. J Clin Invest (1940) 5.45

Resource-based relative values. An overview. JAMA (1988) 4.94

BACTERICIDAL ACTION OF SODIUM SULFAPYRIDINE AND OF A GLUCOSE-SULFAPYRIDINE SOLUTION IN HUMAN BLOOD. J Clin Invest (1940) 4.89

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making (1985) 4.47

THE INFLUENCE OF DOSAGE AND ROUTE OF INJECTION ON THE ANTIBODY RESPONSE OF HUMAN SUBJECTS TO THE SPECIFIC CARBOHYDRATE OF THE TYPE VIII PNEUMOCOCCUS. J Clin Invest (1935) 4.41

Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med (1968) 4.38

Microassay for human and chick cell interferons. Appl Microbiol (1968) 4.20

Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci (1968) 4.00

Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin. Am J Med Sci (1968) 3.78

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother (1976) 3.59

Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol (1977) 3.37

Pathology of Staphylococcal Pneumonia Complicating Clinical Influenza. Am J Pathol (1943) 3.28

Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17

PNEUMOCOCCIC INFECTIONS IN FAMILIES. J Clin Invest (1936) 3.14

Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med (1994) 3.13

The Klebsiella-Enterobacter-Serratia division. Biochemical and serologic characteristics and susceptibility to antibiotics. Ann Intern Med (1966) 3.07

Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother (1973) 3.05

The Klebsiella-Enterobacter-Serratia division. Clinical and epidemiologic characteristics. Ann Intern Med (1966) 2.92

Pathologic Findings in the Lungs of Five Cases from Which Influenza Virus Was Isolated. Am J Pathol (1946) 2.91

Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol (1986) 2.90

Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol (1970) 2.83

Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis (1969) 2.80

Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis (1975) 2.78

Rapid microassay for circulating nephrotoxic antibiotics. Antimicrob Agents Chemother (Bethesda) (1970) 2.73

Results, potential effects, and implementation issues of the Resource-Based Relative Value Scale. JAMA (1988) 2.67

Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Appl Microbiol (1968) 2.55

Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53

Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J Lab Clin Med (1968) 2.45

OBSERVATIONS ON THE URINARY EXCRETION OF SULFADIAZINE. J Clin Invest (1943) 2.44

Use of gentamicin in combinations with other antibiotics. J Infect Dis (1969) 2.37

Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24

An overview of the development and refinement of the Resource-Based Relative Value Scale. The foundation for reform of U.S. physician payment. Med Care (1992) 2.24

Streptomycin-sensitive, -dependent, and -resistant Bacteria. Science (1948) 2.23

AGGLUTININS FOR HUMAN ERYTHROCYTES IN TYPE XIV ANTI-PNEUMOCOCCIC HORSE SERUMS. Science (1938) 2.23

The genital mycoplasmas. N Engl J Med (1973) 2.21

Susceptibility of pneumococci to nine antibiotics. Am J Med Sci (1965) 2.19

Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol (1970) 2.13

Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972. Am J Med (1974) 2.13

Infections and antibiotic use among patients at Boston City Hospital, February, 1967. N Engl J Med (1968) 2.12

Cephaloridine activity in vitro and absorption and urinary excretion in normal young men. Am J Med Sci (1966) 2.09

Results and policy implications of the resource-based relative-value study. N Engl J Med (1988) 2.09

Thiol-group binding of zinc to a beta-lactamase of Bacillus cereus: differential effects on enzyme activity with penicillin and cephalosporins as substrates. J Bacteriol (1968) 2.08

Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol (1968) 2.07

Changing etiology of bacterial endocarditis in the antibacterial era. Experiences at Boston City Hospital 1933-1965. Ann Intern Med (1970) 2.06

[Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris]. Dtsch Med Wochenschr (1999) 2.05

THE NEW PENICILINS. N Engl J Med (1963) 2.02

Methodologic investigations and prevalence of genital mycoplasmas in pregnancy. J Infect Dis (1970) 2.02

Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00

Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci (1997) 1.99

Colonization of newborn infants by mycoplasmas. N Engl J Med (1969) 1.98

Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int (2006) 1.94

Pulmonary nocardiosis. Therapy with minocycline and with erythromycin plus ampicillin. JAMA (1973) 1.94

Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med (1973) 1.92

Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol (1991) 1.92

Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice. J Lab Clin Med (1973) 1.90

Estimating physicians' work for a resource-based relative-value scale. N Engl J Med (1988) 1.88

SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed (1997) 1.88

Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity. Ann N Y Acad Sci (1967) 1.88

Acute otitis media in children. Serologic studies and attempts to isolate viruses and mycoplasmas from aspirated middle-ear fluids. N Engl J Med (1967) 1.87

Elective hysterectomy. Benefits, risks, and costs. Med Care (1985) 1.87

Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis (1974) 1.86

Infection and antibiotic usage at Boston City Hospital: changes in prevalence during the decade 1964-1973. J Infect Dis (1974) 1.83

Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Ann Intern Med (1972) 1.83

The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine (2000) 1.82

Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus). Appl Microbiol (1970) 1.78

Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med (1994) 1.75

Absorption and excretion of five tetracycline analogues in normal young men. Am J Med Sci (1968) 1.72

Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci U S A (1996) 1.72

Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus. Am J Dis Child (1971) 1.71

Molecular cloning and primary structure of myelin-associated glycoprotein. Proc Natl Acad Sci U S A (1987) 1.71

Characteristics of pneumonias caused by Escherichia coli. N Engl J Med (1967) 1.68

Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother (1976) 1.65

Independent segregation of chloramphenicol resistance in Staphylococcus aureus. Antimicrob Agents Chemother (Bethesda) (1967) 1.63

Clinical evaluation of cephaloridine. Arch Intern Med (1968) 1.59

Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc Natl Acad Sci U S A (2000) 1.59

Alteration of GABAA receptor function following gene transfer of the CLC-2 chloride channel. Neuron (1996) 1.56

Infection and antibiotic usage at Boston City Hospital, January 1970. Arch Intern Med (1971) 1.55

The Resource-Based Relative Value Scale. Toward the development of an alternative physician payment system. JAMA (1987) 1.54

Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53

RBRVS: objections to Maloney, I. JAMA (1992) 1.52

Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Arch Intern Med (1970) 1.50

Klebsiella-Enterobacter at Boston City Hospital, 1967. Arch Intern Med (1970) 1.50